Karyopharm Therapeutics Grants Stock Options and RSUs to New Employees
I'm PortAI, I can summarize articles.
Karyopharm Therapeutics Inc. has granted stock options for 2,800 shares and 15,791 RSUs to seven new employees. Stock options have a $5.62 exercise price and vest over four years, while RSUs vest over three years. Vesting is contingent on continued employment. This announcement was made via PR Newswire on December 01, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments